Design Therapeutics, Inc. DSGN Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $16.86M-25.3% | $22.56M+6.4% | $21.2M-20.0% | $26.5M-91.1% | ||
| $202.99M-8.9% | $222.91M-14.5% | $260.6M-14.2% | $303.89M+255% | ||
| $223.78M-9.8% | $248.04M-12.8% | $284.58M-15.1% | $335.12M-13.1% | ||
| $981K-30.4% | $1.41M-16.6% | $1.69M-13.1% | $1.95M+29.1% | ||
| $226.2M-10.3% | $252.09M-13.0% | $289.64M-15.1% | $341.14M-12.7% | ||
| $2.31M+5.8% | $2.19M+12.7% | $1.94M-35.9% | $3.03M+86.7% | ||
| $13.06M+54.3% | $8.46M-12.1% | $9.62M-10.7% | $10.78M+104% | ||
| $13.7M+37.1% | $10M-16.4% | $11.96M-13.5% | $13.83M+64.1% | ||
| $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | ||
| -$297.01M-30.7% | -$227.21M-27.9% | -$177.63M-60.4% | -$110.76M-133% | ||
| $212.5M-12.2% | $242.1M-12.8% | $277.69M-15.2% | $327.31M-14.3% | ||
| $226.2M-10.3% | $252.09M-13.0% | $289.64M-15.1% | $341.14M-12.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Design Therapeutics, Inc.'s total assets?
- Design Therapeutics, Inc. (DSGN) holds $230.4M in total assets, down 3.0% year over year.
- How much debt does Design Therapeutics, Inc. have?
- Design Therapeutics, Inc. carries $2.7M in total debt against $218.1M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Design Therapeutics, Inc. have?
- Design Therapeutics, Inc. holds $12.8M in cash and equivalents.
- Can Design Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 22.28 — current assets exceed current liabilities.
- Where does Design Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Design Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.